麻豆传媒

SAHARA rounds out this year's notable trials on blood transfusions in critically ill patients

Better disease outcomes, measures of cognition, and quality-of-life vs standard care, study finds

Outcomes-based model designed to improve access to pricey treatments

Health news and commentary gathered by 麻豆传媒 staff

USPSTF says new findings were consistent with those of previous review

Pregnant people and those who are immunocompromised most at risk, agency warns

Longer-acting crovalimab designed for more sustained effect and less treatment burden

Indication for HIF-PH inhibitor vadadustat limited to patients already on dialysis

By 12-2 vote, members find improvement in transfusion independence outweighs risk

Agency asking its advisors if benefits outweigh risks for patients who fail on standard treatment

News, features, and commentary about cancer-related issues

Lifetime reduction in acute pain episodes should offset high upfront costs of the therapy

In a phase III trial, momelotinib reduced anemia, constitutional symptoms, and splenomegaly

Commission lays out strategies for progress by 2025 and beyond